BAX and acute lymphoblastic leukemia: This effect may be related to inhibition of Bcl-2 and promotion of Bax gene expression, which suggests crocin can be used as a suitable clinical agent for the treatment of T-lineage acute lymphoblastic leukemia (T-ALL) (112).